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Abstract
Background: Diabetic retinopathy and retinopathy of prematurity are diseases caused by pathological angiogenesis in the
retina as a consequence of local hypoxia. The underlying mechanism for epiretinal neovascularization (tuft formation),
which contributes to blindness, has yet to be identified. Neural cell adhesion molecule (N-CAM) is expressed by Mu¨ller cells
and astrocytes, which are in close contact with the retinal vasculature, during normal developmental angiogenesis.
Methodology/Principal Findings: Notably, during oxygen induced retinopathy (OIR) N-CAM accumulated on astrocytes
surrounding the epiretinal tufts. Here, we show that N-CAM ablation results in reduced vascular tuft formation due to
reduced endothelial cell proliferation despite an elevation in VEGFA mRNA expression, whereas retinal developmental
angiogenesis was unaffected.
Conclusion/Significance: We conclude that N-CAM exhibits a regulatory function in pathological angiogenesis in OIR. This
is a novel finding that can be of clinical relevance in diseases associated with proliferative vasculopathy.
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Introduction
Proliferative vascular malformations are the cause of sight
threatening complications in diseases such as diabetic retinopathy,
the dominant cause of blindness in people ,60 in developed
countries [1], and retinopathy of prematurity (ROP), the primary
cause of blindness in infancy [2]. Common to these complications,
initial retinal ischemia is considered to trigger a series of events
including epiretinal neovascularization, vitreous hemorrhages and
traction retinal detachment, which eventually lead to blindness.
The oxygen induced retinopathy (OIR) model mimics blood vessel
pathologies and has been used to study proliferative retinopathy in
mice [3]. In OIR, mice at postnatal day seven (P7) are exposed to
hyperoxia (75% O2) causing the retinal vasculature to regress
centrally. When returning the mice to normal oxygen level at P12,
the local hypoxia within the capillary free zone induces
revascularization and pathological intravitreous neovasculariza-
tion in the form of epiretinal tuft formation [3,4,5].
Vascular endothelial growth factor A (VEGFA) is a potent
mitogen and chemoattractant for endothelial cells [6,7,8]. VEGFA
induces retinal blood vessel development both under normal
conditions [4] and in pathological proliferative retinopathies [5].
During development of the retinal vasculature, VEGFA is
expressed in two layers of the retina in response to local hypoxia
[4]. After birth, the superficial blood vessel layer develops
peripherally from the optic disc. Astrocytes in the ganglion cell
layer express VEGFA to support endothelial tip cell guidance and
migration [9]. As the retina thickness increases during the first
week, hypoxic conditions stimulate VEGFA expression by cells in
the inner nuclear layer (presumably Mu¨ller cells) [4], leading to
development of the deep blood vessel plexus. Two weeks after
birth the retinal vasculature is largely completed. Crucial for
vasculature formation is VEGFA binding to the extra cellular
matrix (ECM) to build up a gradient around the migrating
endothelial tip cells [9]. This gradient guides the tip cells which are
probing their way with filopodia extensions. Disruption of this
gradient leads to disturbed guidance and defective vascular
development [9]. Although both normal and pathological retinal
angiogenesis stems from local ischemia, there is an essential
difference in the direction of blood vessel growth. In the former,
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the blood vessels are first restricted to the superficial ganglion cell
layer after which they infiltrate the deeper retinal layers. However,
during pathological angiogenesis blood vessels penetrate the
exceeding inner limiting membrane to form intravitreous
epiretinal tufts [3,4,5]. Importantly, the mechanism behind
formation of epiretinal tufts remains unknown, whereas revascu-
larization of the avascular area proceeds as in normal blood vessel
development.
The neural cell adhesion molecule (N-CAM) is expressed
throughout the retina and has pronounced expression in Mu¨ller
cells and astrocytes [10,11,12]. Mu¨ller cells have been reported to
be in close contact with the vasculature, producing matrix
molecules and having important functions in regulating signal
transduction in the retina [11,13,14,15,16]. Astrocytes form the
pre-existing cell layer on which the superficial blood vessel plexus
develops [17,18]. Recently, we showed that N-CAM regulates
pathological angiogenesis during tumor progression [19], suggest-
ing that N-CAM may also be involved in pathologic angiogenesis
of proliferative retinopathy. To address whether N-CAM plays
such a role, we analyzed the consequence of N-CAM ablation on
OIR. Here, we show that during OIR, N-CAM accumulates in
astrocytes closely associated with the tufts. Furthermore, N-CAM-
deficiency resulted in reduced vascular tuft formation and
endothelial cell proliferation, despite an elevation in VEGFA
mRNA expression.
Results
N-CAM ablation does not perturb normal development
of the retinal vasculature
To examine whether N-CAM is required for developmental
angiogenesis in the retina, we studied normal development of the
retinal vasculature in N-CAM-deficient mice. At P10, when the
superficial blood vessel plexus is almost fully developed, N-CAM
expression was localized in the vascular region of the ganglion cell
layer in wild type (wt) mice (Figure 1A). At P7, N-CAM expression
was localized around the GFAP+ astrocytes in close contact with
the vasculature, but even more pronounced in the deeper layers of
the retina (Figure S1A). Ablation of N-CAM resulted in no effect
on radial development or tip cell sprouting, (Figure 1B–D), and
there was no significant difference between wt and N-CAM2/2
when comparing the vessel diameter in the capillary network in
P10 retinas (wt: 7.560.3, N-CAM2/2: 8.060.2, nboth groups = 3.
Epiretinal tufts are surrounded by N-CAM expressing
astrocytes
Notably, N-CAM, which normally is distributed between blood
vessels on astrocytes (S1A), was accumulated around the retinal
tufts during OIR (Figure 2A–D). In OIR, the tufts are surrounded
by astrocytes and can be visualized as GFAP2 spots in areas of tuft
formation (Figure 2E–H). During blood vessel development in the
retina, the blood vessels send out thin filopodia along the pre-
existing astrocyte network. This process is not disturbed in the N-
CAM deficient mice (Figure 2I–L). In OIR the other cell type in
contact with the tufts are pericytes, but since they cover the entire
surface of the tuft (Figure 2M, N) and N-CAM distribution was
limited to the edges, matching the astrocyte location, the probable
source for N-CAM is astrocytes.
N-CAM ablation decreased pathological angiogenesis
without affecting the avascular area in OIR
To examine whether N-CAM affected pathological angiogen-
esis, including retinal revascularization and tuft formation, during
OIR, we analyzed N-CAM-deficient mice after five days in
normoxia (P17). Heterozygous and homozygous N-CAM mutant
animals exhibited a gene-dosage dependent reduction of tuft
formation (Figure 3A–D). The number of tufts was markedly
reduced in N-CAM knock outs compared to wt (Figure S2A). Also
by plotting the distribution of tufts in a size dependent manner, it
can be seen that there were more tufts of all sizes in wt compared
to N-CAM homozygous knock outs (Figure S2B). However, there
was no difference in the size of the avascular area compared to wt
littermates (Figure 3D).
N-CAM ablation does not affect blood vessel leakage
We have earlier reported that N-CAM ablation leads to
increased leakage on tumor blood vessel [19]. To analyze whether
N-CAM has the same effect on the vascular integrity in
pathological angiogenesis during OIR the vasculature of mice
after OIR was perfused with FITC-labeled dextran. The perfusion
revealed no difference in blood vessel leakage in the N-CAM
mutants compared to wt (Figure S1B).
Despite increased VEGFA level in N-CAM deficient
retinas, the proliferation rate in tuft endothelium was
decreased
To analyze whether the reduced size and number of tufts could
be explained by diminished endothelial cell proliferation, we
performed isolectin and BrdU-labeling. Indeed, N-CAM deficient
retinas exhibited a dramatic reduction in endothelial cell prolifer-
ation within tufts (wt= 3.860.3 and N-CAM2/2=1.860.3,
p= 0.005), whereas the remaining vasculature was unaffected
(Figure 4A–D). The proliferation rate was normal in N-CAM
deficient retinas both in the larger vessels (wt= 2.360.6 and N-
CAM2/2=3.260.8, p= 0.39) and in the capillary bed
(wt= 12.561.6 and N-CAM2/2=16.762.1, p= 0.19). It can,
however, not be ruled out that the proliferation of non-endothelial
cells within the tufts and the retinal vasculature also could be
affected by N-CAM deletion.
The blood vessel structure and sprouting of the revasculariza-
tion front appeared similar between N-CAM deficient and control
retinas (Figures 4E–F). The tufts formed by pathologic intravitre-
ous neovascularization also display filopodia (Figure 4G), even
though they appear shorter and point in all directions. No change
in either kind of sprouting was observed in N-CAM deficient mice
during OIR (Figure 4F, H).
To investigate whether the decrease in pathological neovascu-
larization upon N-CAM deficiency was linked to VEGFA
expression changes, VEGFA mRNA levels were quantified at P17
when VEGFA levels are the highest [20]. In contrast to what was
expected, there was an increase in VEGFA mRNA expression,
despite reduced endothelial cell proliferation within the retinal
tufts (Figure 4A–D, I).
Normal perivascular ECM distribution both in the
developing retina and OIR tufts despite N-CAM ablation
To investigate whether N-CAM exhibited similar effects on the
perivascular ECM deposition during pathological angiogenesis in
the retina as during tumor angiogenesis, expression of the
basement membrane proteins collagen IV, fibronectin and laminin
a1/c1 was studied. However, N-CAM ablation resulted in no
change in the expression of these ECM molecules during normal
blood vessel development (Figure 5A–F, and S3) or during OIR
(Figure 5G–L). All ECM molecules tested (collagen IV, laminin
a1/c1 and fibronectin) were evenly distributed on the vasculature
(Figure 5A–F and data not shown). Epiretinal tuft were to a great
N-CAM in OIR Angiogenesis
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extent covered by collagen IV, fibronectin and laminin a1
(Figure 5G–L).
N-CAM ablation affects TGF-b and FGFR mRNA
expression in the retina
In an attempt to elucidate the mechanism behind the tuft
specific decrease in proliferation rate, genes known to control
endothelial cell proliferation, including FGF1, FGF2, TGF-b and
IGF-1 together with genes known to be involved in signaling
together with N-CAM, including FGFR and EGFR, were
analyzed using quantitative PCR (QPCR) on OIR retinas.
Both FGF1 (aFGF) and FGF2 (bFGF) are known to stimulate
endothelial cell proliferation [21,22] but we did not detect any
statistical significant altered mRNA levels in the N-CAM
mutants (Figure 6). TGF-b is known to affect endothelial cells
in various ways and have been implicated both to stimulate and
to inhibit endothelial cell proliferation [23]. For all three
isoforms we detected a statistical significant up regulation in
N-CAM mutant retinas compared to the heterozygote’s, whereas
compared to the wt the up regulation did not reach significance
(Figure 6).
IGF-1 signaling has previously been shown to stimulate
endothelial cell proliferation in OIR [24,25] but we could not
observe any statistically significant mRNA expression changes in
the N-CAM mutants (Figure 6). Both the EGFR and the FGFRs
have been shown to functionally interact with N-CAM [26,27].
FGFR4 was statistically significant upregulated in the N-CAM2/2
mutants compared to the N-CAM+/2 and wt. The expression level
of EGFR was not altered by N-CAM (Figure 6).
Discussion
In OIR, hyperoxia primarily results in blood vessel regression.
Returning to normoxia creates a hypoxic milieu in the avascular
area, which stimulates revascularization and pathologic neovas-
cularization. The normal direction of retinal blood vessel
infiltration due to hypoxia is from the superficial layer down
through the deeper layer of the retina. However, it is not known
why the vessels penetrate the exceeding inner limiting membrane
Figure 1. N-CAM is expressed in the mouse retinal blood vessel layers and N CAM deficiency does not affect the radial blood vessel
development. (A–D) Retinal blood vessels visualized by isolectin staining (red). (A) Confocal image of a wt P10 retina, additionally immunostained
with an antibody against N-CAM (green). As inset in (A) a section from a P17 OIR retina is shown, stained with N-CAM (green) and PECAM (red). The N-
CAM expression is evenly distributed radially over the retina. (B) Statistic analysis of the radial development of the blood vessel plexus at P5 shows
that there is no difference in normal blood vessel development between N-CAM deficient mice and wt controls. The inset picture illustrates the radial
blood vessel development at P5. Statistical method used was Student t-test. (nwt = 15, nN-CAM+/2= 19, nN-CAM2/2= 16). (C, D). Confocal images of
sprouting tip cells in the border of the developing vasculature at P5 show that the sprouting in the N-CAM deficient retina (D) is identical to the wt
(C). Arrowheads indicate filopodia which are stained by isolectin. Scale bars are 100 mm (A), and 50 mm (C).
doi:10.1371/journal.pone.0026026.g001
N-CAM in OIR Angiogenesis
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to form epiretinal tufts under pathological conditions. Although
the tufts appear malfunctional, they provide the underlying retina
with physiological oxygen levels, which presumably lower VEGFA
expression by the astrocytes [28].
In the present study we show that N-CAM ablation does not
affect the normal developmental retinal angiogenesis or the
revascularization of the retina after OIR but decreases, in a
gene-dosage dependent way, the epiretinal tuft formation.
During normal retinal development N-CAM is expressed in a
pattern suggesting that astrocytes are the cell of origin close to the
vasculature. After OIR N-CAM is accumulated around the
epiretinal tufts, also indicating astrocytic origin. Even though
Figure 2. N-CAM is expressed by astrocytes around the epiretinal tufts. (A–N) Confocal images of retinal blood vessels, visualized by
isolectin (red) and additionally stained with antibodies against N-CAM (A–D), GFAP (E–L) and NG2 (M, N) (green). N-CAM is accumulated around the
epiretinal tufts (A, B), probably expressed by the surrounding GFAP+ astrocytes (E, H). The tufts give rise to empty (GFAP2) spots in the astrocyte layer
(indicated by arrows in F and H). (C, D) Negative controls of N-CAM expression in N-CAM deficient retinas. (I, K) Overview pictures of the vascular front
at P5. The marked square is enlarged in (J, L), arrowheads mark the filopodia attachment to the GFAP+ astrocytes. The astrocyte layer appeared
identical in wt (E, F, I, J) and N-CAM deficient retinas (G, H, K, L). (M, N) NG2+ pericytes cover the tufts in both wt (M) and N-CAM deficient (N) retinas.
Scale bars are 20 mm (A–D, J, L, M, N), 40 mm (E–H) and 50 mm (I, K).
doi:10.1371/journal.pone.0026026.g002
N-CAM in OIR Angiogenesis
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astrocytes seem to be the probable source of N-CAM we cannot
rule out that other cell types, as Mu¨ller cell and microglia, also
express N-CAM.
In agreement with our observations that the revascularization
was unaffected whereas the tuft formation was decreased, the
reduced endothelial proliferation rate was restricted to the tufts.
The migrating endothelial front uses tip cell filopodia extensions
to guide their movement by following the pre-existing VEGFA
expressing astrocyte network [9]. Deficient sprout establishment
could potentially lead to reduced endothelial cell migration and
proliferation [9]. In the N-CAM deficient retinas, tip cell sprouting
was unaffected both during normal development and OIR. In
OIR the epiretinal tufts also produce short and randomly directed
sprouts of which neither was affected in the N-CAM deficient
retinas.
A VEGFA gradient has been shown to be crucial for endothelial
migration and proliferation in the retina [9,29]. Whereas VEGFA
is essential for developmental angiogenesis within the retina [4], it
has also been associated with pathologic angiogenesis in ocular
diseases [30,31,32,33]. VEGFA is encoded by one gene, which
after alternative splicing generates at least three major isoforms;
VEGFA188, VEGFA164 and VEGFA120 [34]. Guidance of tip cell
filopodia is dependent on the correct relationship between the
expression levels of all three isoforms. Therefore, disturbed
expression of any of the isoforms may cause defective filopodia
guidance, endothelial migration and proliferation [9]. It was
therefore of interest to analyze the effect of N-CAM ablation on
the expression level of each isoform. In agreement with previous
studies, the 164 isoform was the most abundant, followed by 120
and 188 (data not shown) [35]. Statistical analysis failed to reveal
significant differences in VEGFA isoform expression between N-
CAM mutant and wt retinas in OIR, suggesting that the reduced
EC proliferation is not due to altered VEGFA levels. N-CAM may
thus regulate endothelial cell proliferation by VEGFA-indepen-
dent pathways. One such pathway is endothelial nitric oxide
synthase (eNOS)-mediated signaling [36]. Nitric oxide (NO) is a
free radical produced by NOS of which there are three variants.
eNOS, predominantly expressed in the plasma membrane of
vascular endothelial cells [37,38], has been implicated to play a
proangiogenic role [39,40]. Mice deficient in eNOS express an
OIR phenotype, which is very similar to the one presented in this
work, with less pathologic angiogenesis and elevated VEGFA
Figure 3. N-CAM deficiency leads to decreased pathological angiogenesis but unaffected avascular area in OIR. (A–C) Retinal blood
vessels visualized by isolectin staining illustrating the tuft formation (arrows) and avascular area (arrowheads) at P17 in OIR in wt (A), heterozygous-
(B) and homozygous (C) N-CAM mutated retinas. (D) Statistic analysis of tuft formation and avascular area showing a linear decrease in tuft formation
from wt to homozygous N-CAM deletion, but unaffected avascular area. Statistical method used was Student t-test (nwt = 15, nN-CAM+/2= 19, nN-CAM2/2=
16). * = p,0.05. Scale bar is 1 cm.
doi:10.1371/journal.pone.0026026.g003
N-CAM in OIR Angiogenesis
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levels [36]. To investigate whether eNOS was transcriptionally
regulated in N-CAM deficient OIR retinas we measured eNOS
mRNA expression levels. No difference in eNOS mRNA
expression was detected between N-CAM mutant and wt retinas.
To further elucidate the mechanism behind the reduced
proliferation in the vascular tufts, the expression of genes known
to play a role in endothelial cell proliferation or N-CAM signaling
were analyzed by QPCR on OIR retinas. Among the genes
analyzed, all three isoforms of TGF-b and FGFR4 were up
regulated in N-CAM2/2. However, since N-CAM only affects
pathological angiogenesis, RNA extraction from whole retina
might not be sensitive enough to pick up changes in mRNA
expression only from the pathological vasculature. Both TGF-b
and FGFR4 could play a role in the mechanism by which N-CAM
regulates tuft formation during OIR.
N-CAM deficiency may also directly or indirectly affect the
distribution of growth factors bound to the ECM. It has previously
been shown that if the basement membrane of blood vessel is
Figure 4. Decreased proliferation in tuft endothelium despite increased VEGFA level in N-CAM deficient retinas in OIR. (A–H)
Confocal images of retinal blood vessels, visualized by isolectin (red). (A–D) Additional antibody staining against BrdU to view the proliferating nuclei
(green). (A, B) Decrease in endothelial cell proliferation in N-CAM deficient retinas (B) compared to wt (A) was restricted to the tufts, whereas the
remaining vasculature was unaffected (arrowheads indicate veins). (C, D) High magnification of an epiretinal tuft with a clear down regulation of
endothelium proliferation in N-CAM deficient retina (D) compared to wt (C). (E–H) Endothelial sprouting in the revascularization of the avascular area
(E, F), and in the tufts (G, H), after OIR treatment. There was no change in sprouting in N-CAM deficient mice (F, H) compared to wt (E, G). Arrowheads
indicate the sprouts. (I) Graphic illustration of mRNA quantification by QPCR of VEGFA levels in retinas at P17 after OIR treatment. N-CAM deficient
mice exhibited a 40% increase in total VEGFA mRNA expression. Although not significant with a 5% level of significance, there is a tendency of
increase in all isoforms with the highest relative elevation in VEGFA120. Statistical method used was Student t-test. (nwt = 5, nN-CAM+/2= 2, nN-CAM2/2= 4).
Scale bars are 100 mm (A, B) and 20 mm (C–H).
doi:10.1371/journal.pone.0026026.g004
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injured or degraded, e.g. by defective ECM deposition, the
underlying endothelial and mural cells get intimately exposed to
surrounding growth factors and respond by starting to proliferate
[41,42]. Consistently, ECM molecules have been implicated in
endothelial cell proliferation during angiogenesis [43]. We
previously showed that N-CAM-deficiency during tumor progres-
sion resulted in diminished expression of ECM components and
defective perivascular ECM deposition [19]. Further, N-CAM has
been shown to inhibit expression of matrix degrading enzymes
(matrix metalloproteinases, MMPs) [44] which could indicate a
proliferation promoting property. In this study, the proliferation in
the pathological retinal tufts was down regulated in N-CAM-
deficient mice which rather would expect ECM-inhibiting or
MMP-promoting properties of N-CAM. We found no evidence
Figure 5. N-CAM deficiency does not affect the ECM distribution in the developing retina or in OIR tufts. (A–F) Overview images of
retinas stained with antibodies against collagen IV (A, D, G, J), fibronectin (B, E, H, K) or laminin a1 (C, F, I, L) (red). Collagen IV, fibronectin and laminin
a1 were expressed in the whole developing retinal vasculature at P5 (A–C). Expression analysis of ECM components after OIR revealed a strong
expression of collagen IV (G, J), fibronectin (H, K) and laminin a1 (I, L) (green) around the epiretinal tufts, visualized by isolectin (red). No differences
were observed in the N-CAM deficient animals (D–F, J–L). Scale bar is 20 mm.
doi:10.1371/journal.pone.0026026.g005
N-CAM in OIR Angiogenesis
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that N-CAM deficiency has any effect on ECM components in the
retina during normal development or OIR. It can, however, not
be ruled out that other ECM components than the ones examined
in this study might be affected in the N-CAM mutants. Further
studies are needed to reveal whether there are mechanistically
differences in N-CAM’s role during OIR and tumor angiogenesis.
In conclusion, we show that N-CAM is involved in hypoxia
regulated endothelial cell proliferation in vivo. Hypoxia-exposure in
the OIR model resulted in a gene-dosage dependent decrease in
pathological angiogenesis, as revealed by reduced formation of
epiretinal tufts, in N-CAM heterozygous and homozygous mice,
whereas normal retinal vasculature development appeared
unaffected. These observations are consistent with our recent
finding that N-CAM deletion limits pathological angiogenesis
during tumor progression [19]. Altogether, these findings
emphasize a novel role of N-CAM in pathological angiogenesis.
However, the underlying mechanism for N-CAM’s role in
pathological angiogenesis during tumorigenesis and OIR appears
to differ. Whereas N-CAM maintains vessel integrity by promoting
pericyte-endothelial cell-cell interactions during tumor angiogen-
esis, N-CAM is required for endothelial cell proliferation during
formation of the epiretinal tufts. The distinct accumulation of N-
CAM around the epiretinal tufts suggests a potential role in their
formation during OIR. Indeed, N-CAM ablation resulted in a
decrease in endothelial cell proliferation specifically within tufts,
which presumably explains the reduction in tuft formation. This
finding would be consistent with reduced expression of the major
proliferation growth factor VEGFA. However, instead, we found
that VEGFA mRNA expression was increased in N-CAM2/2
mice relative to the controls. The increase in VEGFA levels could
either be a compensatory effect of the defective proliferative
response, or a consequence of reduced formation of epiretinal
tufts, which normally lower VEGFA expression in astrocytes after
providing the underlying retina with higher oxygen levels [28].
By screening several genes involved in endothelial cell
proliferation or N-CAM signaling we identified TGF-b and
FGFR4 to be potential mechanistically targets of N-CAM in
vascular tuft formation.
Based on our findings, we propose that N-CAM may be a
potential target of clinical relevance for diseases caused by
proliferative retinopathy in humans.
Materials and Methods
Ethical statement/Mice
N-CAM+/2 (with C57/BL6 background) [45] mice were bred
to generate wt, N-CAM+/2 and N-CAM2/2 littermates. They
were housed and bred in accordance with regulations for the
protection of laboratory animals, after approval from the local
ethical committee. The animals were housed on a 12:12-hour
light–dark cycle and food and water were available ad libitum.
Tissues
Oxygen induced retinopathy (OIR); Mice at postnatal day 7 (P7) were
exposed to 75% oxygen for 5 days together with their mothers in
an oxygen chamber [3], the oxygen concentration was checked
daily. The mice were then transferred back to normal air (21%
oxygen) for 5 days after which the mice were sacrificed and the
eyes were dissected for whole mount immunostainings.
Others; Mice at P5, P7 and P10, respectively, were sacrificed and
eyes were dissected for immunostainings.
The FITC dextran perfusions were carried out as previously
reported [46].
Immunohistochemistry
Retinas were prepared and stained according to earlier
published protocol [9]. Shortly, the mice were sacrificed and the
eyes collected and placed in PBS on ice. After a short (2 minutes)
fixation in 4% PFA the retina was dissected. To avoid damage to
the epiretinal tufts during this procedure the hyaloid vessels were
gently removed. The retina was then fixed for an additional
2 hours. The blood vessels were visualized by staining with
biotinylated isolectin B4 (Bandeiraea simplicifolia) (L-2140; Sigma-
Aldrich). Antibodies used were; rabbit anti-N-CAM (1:100
dilution; a gift from Dr. E. Bock), rat ant-N-CAM (1:100; Abcam),
goat-anti PECAM (1:500; R&D), FITC-conjugated rat anti-BrdU
(1:200; Nordic Biosite), rabbit anti-GFAP (1:100; Sigma), rabbit
anti-collagen IV (1:250; Biogenesis), rabbit anti-fibronectin (1:200;
DAKO), mouse monoclonal anti-laminin a1 (generous gift from
Dr. P. Ekblom), rabbit anti-laminin c1 (generous gift from Dr. M.
Durbeej-Hjalt) rabbit anti-NG2 (1:200; Chemicon). Conjugated
secondary antibodies from Molecular Probes and Jackson
ImmunoResearch Laboratories were used. Flat mounted retinas
or sections were analyzed by fluorescence microscopy using a
Nikon E1000 or a Zeiss Axioplan 2 microscope and by confocal
laser scanning microscopy using a Leica LCS NT or Zeiss LSM
780. Images were processed using Adobe PhotoshopH and or
Imaris.
QPCR
Retinas frommice exposed to the OIR treatment were dissected in
ice cold PBS and total RNA was prepared using the RNeasy mini kit
(Qiagen) with the RNase free DNase (Qiagen) treatment according to
the manufacturer’s instructions. Reverse transcription (iScript,
BioRad) and QPCR assays using SYBR Green I as detection
chemistry was performed as described [47]. Primer sequences are
shown in Table S1. PCR products were checked by agarose gel
electrophoresis and melting curve analysis. Expression data were
normalized against Tubb5. The expression level of VEGFA188 was
found to be significantly lower (,10 fold) than the expression of
VEGFA188+164, consequently VEGFA188+164,VEGFA164. The ratio
between VEGFA188+164 and VEGFA188+164+120 (,VEGFA164 :
VEGFA164+120) gives the relative difference in expression level
between the VEGFA164 and VEGFA120 isoforms.
Blood vessel area quantification
Pictures of whole mount retinas after OIR were taken at 2006.
For measurement of tuft-, avascular-, and total retina-area the
Velocity software was used, and by modulating intensity settings
the different areas could be quantified. By letting the software
identify only the parts of the vasculature with highest intensity of
the isolectin staining, the tufts were marked and the area for each
tuft was quantified. By letting the software identify the area with
any staining at all, including the very low background, the total
Figure 6. N-CAM affects TGF-b and FGFR4 expression levels in retinas during OIR. QPCR was used to quantify the expression of
vascular related genes in retinas after OIR. All isoforms of TGF-b (nwt = 6, nN-CAM+/2= 8, nN-CAM2/2= 7), were upregulated in N-CAM
2/2, FGFR4
(nwt = 6, nN-CAM+/2= 8, nN-CAM2/2= 7) was significant upregulated in the N-CAM
2/2 mutants compared to the N-CAM+/2 and wt whereas the other
genes were not statistically significantly altered, eNOS ( nwt = 5, nN-CAM+/2= 3, nN-CAM2/2= 4), IGF-1, FGF1, FGF2, FGFR2, FGFR3and EGFR (nwt = 6,
nN-CAM+/2= 8, nN-CAM2/2= 7). Statistical method used was Student t-test. * = p,0.05.
doi:10.1371/journal.pone.0026026.g006
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retina was marked and the area was quantified. By setting the
intensity level very low, the avascular part in center of the retina
was marked, and the area was quantified.
Blood vessel diameter measurement
Pictures of P10 whole mount isolectin stained retinas were taken
att 2006. The vessel diameter (measured in the computer software
Photoshop CS) was measured on 30 blood vessels of the capillary
network in 3 wt and N-CAM2/2 mice. The data is presented in
length units as average 6SEM.
ECM quantification
P5 retina samples were stained for PECAM and fibronectin or
collagen IV or laminin c1. One field/retina (206objective) in the
capillary bed was scanned using Zeiss LSM 780 confocal.
Using Imaris the blood vessel volumes (PECAM) and the ECM
volumes were quantified. The ECM volume/blood vessel volume
were compared between wt and N-CAM2/2. The data was
normalized to wt and presented as average 6SEM. nall groups = 5.
Quantification of endothelial cell proliferation retinas
after OIR
Pictures of whole mount retinas after OIR were taken at 2006.
Tufts. BrdU labeled cells were counted in 338 tufts from 3
wild type retinas and 123 tufts from N-CAM2/2 retinas. The area
of each tuft was measured with the same technique as mention
above in the section ‘‘blood vessel quantification’’. The number of
BrdU labeled cells per tuft area unit was calculated and the
average was calculated for each retina. Student t-test was
performed on n=3. The data is presented as average 6SEM
BrdU-labeled cells/area unit.
Capillaries. BrdU labeled cells were counted in 34 fields of
the capillary network of 3 wt retinas and 29 fields of the capillary
network of N-CAM2/2retinas. The area was measured in
Photoshop and the number of BrdU labeled cells per area unit
was calculated. The average was calculated for each retina and
Student t-test was performed on n= 3. The data is presented as
average 6SEM BrdU-labeled cells/area unit.
Large vessels. BrdU labeled cells were counted in 24 large
vessels of 3 wt retinas and 28 large vessels of N-CAM2/2retinas.
The length of each vessel was measured in Photoshop and the
number of BrdU labeled cells per length unit was calculated. The
average was calculated for each retina and Student t-test was
performed on n=3. The data is presented as average 6SEM
BrdU-labeled cells/length unit.
Supporting Information
Figure S1 N-CAM is expressed in the mouse retinal
blood vessel layers and co-localize with astrocytes and
N-CAM ablation does not affect blood vessel leakage in
retinas after OIR. (A) Retinal sections from wt P7 were stained
for N-CAM (green), PECAM (blue) and GFAP (red). N-CAM was
expressed in the blood vessel layer and co-localize with GFAP
expressing astrocytes but is also expressed in deeper retinal layers.
Astrocytes enter the retina from the optic nerve (on) and first form
a superficial plexus which is seen as the GFAP+ rim close to the
vitreous body. As insets high magnification optical sections are
shown. Scale bar = 100 mm. (B) FITC-dextran (green) perfusion of
retinas after OIR revealed almost no leakage of the retinal
vasculature and there was no difference between N-CAM2/2 and
wt. Isolectin staining (red), FITC-labeled dextran (green).
(TIF)
Figure S2 N-CAM ablation decreases the number of
tufts. (A) The total number of tufts per retina was 2.8 times higher
in WT compared to NCAM2/2 (Student t-test, p,0.05, n = 3 for
WT and NCAM2/2). (B) The tuft areas were lognormally
distributed in both WT and NCAM2/2 and the number of
tufts was lower for NCAM2/2 than WT for all sizes of area. (Tuft
areas were pooled for 3 WT and 3 NCAM2/2 mice, respectively).
(TIF)
Figure S3 ECM volume quantification. The blood vessel
volumes (PECAM) and ECM (fibronectin, collagen IV and
laminin c1 respectively) volumes were quantified in p5 retina
samples using confocal microscopy and Imaris software. The
ECM volume/blood vessel volume were compared between wt
and N-CAM deficient retinas, no significant difference could be
detected, collagen IV p=0,8026, fibronectin p= 0,2705 and
laminin c1 p= 0,8002.
(TIF)
Table S1 QPCR primer sequences.
(DOCX)
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